12:01 PM EST - ProMetic Life Sciences Inc : announced today that it has won a first order from a leading Chinese biopharmaceutical company for a large scale biomanufacturing process, successfully continuing to expand its reach in Asia. Revenues arising from projects like this are typically in the range of $3-5 million per year. ProMetic Life Sciences Inc
shares T.PLI are trading even at $0.11.
